VCU
CalendarCoursesMapsNewsVCU A-ZE-mail
 
Search Events Calendar
Today's Events

 


Detailed Search

  Jul 2014   ->
Click on Date for Daily Events
SMTWTFS
  12345
6789101112
13141516171819
20212223242526
2728293031  

View archived events

Submit an Event

Other Calendars
Final Exam Schedule
Academic Calendars
VCU Holiday Schedule
Richmond, Virginia

About the Calendar

 
Fighting Cancer with Nanoparticle Medicines: The Nanoscale Matters
  Print Print this event   Add to calendarhttp://02-04-2013 16:30:0002-04-2013 18:00:0015Fighting Cancer with Nanoparticle Medicines: The Nanoscale MattersFighting Cancer with Nanoparticle Medicines: The Nanoscale MattersEngineering West Hall - Ethyl Auditorium - Rm 101Jack Schreiberjbschrei@vcu.eduDD/MM/YYYY
 
Date and Time   Tuesday, April 2, 2013
4:30 pm - 6:00 pm

 
Location   Engineering West Hall - Ethyl Auditorium - Rm 101,   Monroe Park Campus
 
Sponsor(s)   Engineering:Chemical & Life Science Engineering
 
Speaker   Mark E. Davis, Ph.D. Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology
 
Audience   VCU Alumni, VCU Faculty, VCU Health Care Providers, VCU Physicians, VCU Staff, VCU Students , Administration , Community Based Physicians, New Students, School of Medicine
 
Description   Professor Davis is a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He is also the author of more than 375 scientific publications, two textbooks and over 50 patents and presents as a distinguished lecturer in the third annual Henry A. McGee, Jr. Ph.D. Chemical and Life Science Engineering lecture series. Professor Davis will present the current understandings of why engineered, nanosized medicines that are highly multifunctional chemical systems have the potential to provide game changing ways to treat cancer. The nanoscale matters. He will illustrate this point by demonstrating how physical insights at the nanoscale allow for the development of nanoparticles that can function as intended in animals and humans. The data from humans will be used to show how he and his research team have translated two independent nanoparticle cancer therapeutics from laboratory curiosities to experimental therapeutics in human clinical trials.
 
Related Links:   Mark E. Davis, Ph.D. Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology
VCU School of Engineering Department of Chemical and Life Science Engineering
 
Contact
Information
  Jack Schreiber
804 828 7789
jbschrei@vcu.edu

 
Special
Needs
  Jack Schreiber
804 828 7789
jbschrei@vcu.edu
 

Virginia Commonwealth University | Events Calendar
Please send comments to the Calendar Coordinator
© 1997-2014 Virginia Commonwealth University